Ingredient news
EFSA Lists Lacto-N-Triose II Opinion in Recent Novel-Food Activity
By Nutranexa News |
EFSA lists a July 2026 scientific opinion on lacto-N-triose II as a novel food under the EU novel-food regulation.
What Was Reported
EFSA's novel-food topic page lists a scientific opinion on the safety of lacto-N-triose II as a novel food pursuant to Regulation (EU) 2015/2283, published July 22, 2026.
The entry demonstrates the continuing range of novel-food applications, but it is specific to the substance and dossier assessed. It does not change the legal identity or evidence required for phosphatidylserine.
Ingredient Buyer Context
A supplier questionnaire should name the exact substance, source, production method, proposed food category, and market. If the customer asks for a novel-food statement for PS, respond with product-specific evidence or a documented limitation rather than a broad list of unrelated EFSA opinions.
The source concerns the named study, company, agency, or market development. It should not be expanded into a medical treatment claim, a universal ingredient result, or a guarantee about a supplier or finished product.
Nutranexa Takeaway
This is a regulatory activity note and not a Nutranexa product claim.
For a product-specific discussion, provide the target market, application, source preference, PS grade, annual quantity, packaging, and required documents. Nutranexa can then discuss the relevant product and quality evidence without assuming facts that are not in the current controlled file.